07 session he chaired entitled "ST Elevation Myocardial Infarction: The First 24 Hours." Dr. Smith: I'm Dr. Sidney Smith and with me is Dr. Elliott Antman, director of the Samuel A. Levine Cardiac ...

Myocardial infarction or 'heart attack' is a type of acute coronary syndrome in which sudden blockage of a coronary artery, and subsequent myocardial ischaemia, results in damage to the ...

A non-transmural myocardial infarction refers to a myocardial infarction that does not involve the full thickness of the myocardium. It was one believed that the development of Q waves indicated ...

In patients with acute heart failure, it is unclear how body mass index affects clinical outcomes following acute myocardial infarction.

SGLT2 inhibitors vs placebo were associated with reduced heart failure hospitalization among patients with history of myocardial infarction.

was associated with favorable outcomes in patients with stabilized acute myocardial infarction (AMI) having a body mass index (BMI) less than 28 but not in those with a higher BMI. This post hoc ...

Research has linked higher levels of air pollution to the risk of acute myocardial infarctions, or heart attacks. How these ...

An anterior myocardial infarction results from occlusion of the left anterior descending coronary artery. This can cause an ST elevation myocardial infarction or a non-ST segment elevation ...

Following injury, many organs are capable of rapid regeneration of necrotic tissue to regain normal function. In contrast, ...

A new review published in Genes & Diseases highlights macrophage-targeted therapy as a promising frontier in cardiac regeneration and myocardial repair.

The dual SGLT1/2 inhibitor yielded a 32% reduction in myocardial infarction risk and 34% reduction in stroke risk. It's first SGLT inhibitor to provide a significant reduction in both myocardial ...